The company is a biotechnology enterprise that conducts technology research and product development around functional proteins and polymer organic materials such as enzymes, antigens, and antibodies. Relying on self-established key common technology platforms, it has successively entered business fields such as life science, in vitro diagnosis, biomedicine, etc., and is one of the few innovative R&D enterprises in China that also has autonomous and controlled upstream technology development capabilities and terminal product production capabilities. It is committed to intelligently manufacturing “biochips” and continues to inject new vitality into the development of the biotechnology industry. The company's business mainly revolves around the three business segments of life science, in vitro diagnosis, and biomedicine, covering R&D, production and sales of biological research reagents, genetic sequencing reagents, experimental instruments and consumables, diagnostic materials, diagnostic reagents and instruments, biomedical reagents, vaccine raw materials, etc., as well as technical services such as vaccine clinical/pre-clinical biological sample testing services and antibody discovery. Main products: biological research reagents, genetic sequencing reagents, laboratory instruments and consumables, diagnostic raw materials, diagnostic reagents and instruments, biomedical reagents, vaccine raw materials and other products. Corporate honors: National specialty, special and new “little giant” enterprises, etc.
No Data